Vor Biopharma CEO Robert Ang designated Principal Financial Officer and Principal Accounting Officer

Vor Biopharma Inc.

Board designated CEO Robert Ang as principal financial and accounting officer effective May 19, 2025.
No new compensation arrangements were entered into or amended in connection with the designation.
Dr. Ang continues as President, CEO, and director.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert Ang

Principal Financial Officer and Principal Accounting Officer

VOR · Vor Biopharma Inc.

Effective: 2025-05-19
Filed: May 20, 2025 23:59 UTC

On May 19, 2024, the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) designated Robert Ang, M.B.B.S., M.B.A., the Company’s President and Chief Executive Officer and a director of the Company, as the Company’s principal financial officer and principal accounting officer.

Source: SEC EDGAR

accession 0001193125-25-123141

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.